Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing ultrasound-guided ablation and laparoscopic surgery for adrenal tumors

Official title: Resident Doctor, Master Degree Candidate

Run by Third Affiliated Hospital, Sun Yat-Sen University · NCT05991856 · Data updated 2026-11-12

This study is testing whether ultrasound-guided radiofrequency ablation is as safe and effective as laparoscopic surgery for treating adrenal tumors in patients with aldosterone-producing adenoma.

More Radiofrequency Ablation trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorThird Affiliated Hospital, Sun Yat-Sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedJanuary 1, 2020
Main results expectedOctober 1, 2024
Study endsDecember 1, 2030
Registry record updatedAugust 15, 2023
Trial IDNCT05991856 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with confirmed unilateral aldosterone-producing adenoma.

Probably not a fit

Patients with bilateral adrenal diseases, multiple adrenal tumors, or other adrenal conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to analyze the efficacy and safety of ultrasound-guided radiofrequency ablation versus laparoscopic adrenalectomy for treating aldosterone-producing adenoma (APA). It will involve a retrospective collection of data from 30 patients who underwent radiofrequency ablation and 15 patients who had laparoscopic adrenalectomy, matched by age and sex. The study will follow these patients for three years to assess long-term outcomes. This research is significant as it is one of the first to compare these two treatment methods in a larger cohort.

Why it matters

Potential benefit: If successful, this study could provide insights into a less invasive treatment option for patients with aldosterone-producing adenoma.

How similar studies have gone: While there have been few studies on this topic, the approach of using ultrasound-guided radiofrequency ablation is relatively novel and has shown promising results in preliminary cases.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. APA was confirmed with unilateral lesions;
2. Benign tumor without adrenal metastasis and endovascular tumor embolus;
3. Receive ultrasound-guided adrenal RFA treatment or laparoscopic resection, and sign the informed consent for surgery;
4. Age ≥ 18;
5. Age ≥ 40 years old should meet the following criteria: blood potassium ≤3.5mmol/L; PAC≥20ng/dL; PRC≤5μIU/mL; A unilateral adrenal nodule of 10mm or more was completely normal on the opposite side.

Exclusion Criteria:

1. Bilateral adrenal diseases;
2. Multiple adrenal tumors;
3. Other adrenal diseases, such as adrenal hyperplasia, Cushing's syndrome, pheochromocytoma, etc.;
4. Imaging suggests that the tumor may be difficult to reach;
5. Imaging showed potential malignant adrenal tumor;
6. Pregnant and/or planning a pregnancy;
7. Refusing to participate in follow-up visits.

Where it's running

  • The Third Affiliated Hospital of Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.